Posted by Michael Wonder on 29 Aug 2020
FDA ousts spokeswoman after COVID therapy misstatements
29 August 2020 - Emily Miller joined the agency as chief spokeswoman this month.
The U.S. FDA has ousted its chief spokeswoman, according to a person with knowledge of the move, after the head of the agency exaggerated the benefits of an experimental therapy and others in the Trump administration promoted the erroneous statements.
The spokeswoman, Emily Miller, joined the agency earlier this month. She came to the job with communications experience in past government positions, a stint at conservative media outlets, and work advocating for gun rights. But she had little to no health care experience.
